BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8302604)

  • 1. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.
    Pulverer BJ; Fisher C; Vousden K; Littlewood T; Evan G; Woodgett JR
    Oncogene; 1994 Jan; 9(1):59-70. PubMed ID: 8302604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.
    Henriksson M; Bakardjiev A; Klein G; Lüscher B
    Oncogene; 1993 Dec; 8(12):3199-209. PubMed ID: 8247524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site.
    Saksela K; Mäkelä TP; Hughes K; Woodgett JR; Alitalo K
    Oncogene; 1992 Feb; 7(2):347-53. PubMed ID: 1312697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of bovine leukemia virus Tax protein is required for in vitro transformation but not for transactivation.
    Willems L; Grimonpont C; Kerkhofs P; Capiau C; Gheysen D; Conrath K; Roussef R; Mamoun R; Portetelle D; Burny A; Adam E; Lefèbvre L; Twizere JC; Heremans H; Kettmann R
    Oncogene; 1998 Apr; 16(17):2165-76. PubMed ID: 9619825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional repression activity of N-MYC protein requires phosphorylation by MAP kinase.
    Manabe A; Iguchi-Ariga SM; Iizuka H; Ariga H
    Biochem Biophys Res Commun; 1996 Feb; 219(3):813-23. PubMed ID: 8645263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of c-Myc and cell immortalization alters c-Myc phosphorylation.
    Lutterbach B; Hann SR
    Oncogene; 1997 Feb; 14(8):967-75. PubMed ID: 9050996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2/c-erbB2 is phosphorylated by calmodulin-dependent protein kinase II on a single site in the cytoplasmic tail at threonine-1172.
    Feinmesser RL; Gray K; Means AR; Chantry A
    Oncogene; 1996 Jun; 12(12):2725-30. PubMed ID: 8700533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of mutant and wild-type MC29 v-myc alleles and biochemical properties of their protein products.
    Bister K; Trachmann C; Jansen HW; Schroeer B; Patschinsky T
    Oncogene; 1987 May; 1(2):97-109. PubMed ID: 3438084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
    Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
    Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single serine residue at position 375 of VP16 is critical for complex assembly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II.
    O'Reilly D; Hanscombe O; O'Hare P
    EMBO J; 1997 May; 16(9):2420-30. PubMed ID: 9171355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
    Min S; Mascarenhas NT; Taparowsky EJ
    Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity.
    Chen RH; Juo PC; Curran T; Blenis J
    Oncogene; 1996 Apr; 12(7):1493-502. PubMed ID: 8622865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.
    Albert T; Urlbauer B; Kohlhuber F; Hammersen B; Eick D
    Oncogene; 1994 Mar; 9(3):759-63. PubMed ID: 8108117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium.
    Bryan JT; Han A; Fife KH; Brown DR
    Virology; 2000 Mar; 268(2):430-9. PubMed ID: 10704351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
    Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
    Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
    Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor-associated protein (RAP) binds calmodulin and is phosphorylated by calmodulin-dependent kinase II.
    Petersen CM; Ellgaard L; Nykjaer A; Vilhardt F; Vorum H; Thøgersen HC; Nielsen MS; Jacobsen C; Moestrup SK; Gliemann J
    EMBO J; 1996 Aug; 15(16):4165-73. PubMed ID: 8861945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK.
    Murakami M; Ui M; Iba H
    Cell Growth Differ; 1999 May; 10(5):333-42. PubMed ID: 10359014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.